Immunotherapies Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NEXI | F | NexImmune, Inc. | -3.81 | |
GRTS | F | Gritstone Oncology, Inc. | -5.00 | |
GMAB | F | Genmab A/S | 0.38 | |
ALPN | F | Alpine Immune Sciences, Inc. | 0.00 | |
IMCR | F | Immunocore Holdings plc | 2.00 | |
GOVX | F | GeoVax Labs, Inc. | -1.43 | |
EVAX | F | Evaxion Biotech A/S | -3.59 | |
HCWB | F | HCW Biologics Inc. | 2.39 | |
SABS | F | SAB Biotherapeutics, Inc. | 6.51 | |
AFMD | F | Affimed Therapeutics B.V. | -1.53 |
Related Industries: Biotechnology Long-Term Care Facilities Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | B | ALPS Medical Breakthroughs ETF | 5.72 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 4.61 | |
CNCR | C | Loncar Cancer Immunotherapy ETF | 3.34 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 2.88 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.89 |
Compare ETFs
- Immunotherapies
Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles